share_log
Reuters ·  Jan 31 00:52
U.S. FDA Approves Celltrion's Avtozma® (Tocilizumab-Anoh), a Biosimilar to Actemra®
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 271

Recommended

Write a comment